TetraGenetics, an AbCellera company, empowers antibody discovery against difficult-to-drug targets by providing recombinant transmembrane proteins, including human ion channels, G protein-coupled receptors and other transmembrane proteins.
TetraGenetics’ protein production platform, TetraExpress™, uses the protist Tetrahymena thermophila to quickly produce large quantities of properly folded, functional transmembrane proteins, which are challenging to express using conventional systems.
Tetragenetics is excited to announce we are now an AbCellera company.
Read more about our acquisition here.